000			01820nam a2200349 4500
001			7680
010			_a9291681814
090			_a7680
100			_a20040727d2004 y0pory50 ba
101			_aeng
200			_aReport on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction
210			_aLuxembourg _cOffice for Official Publications of the European Communities _d2004
215			_a136 p. _cil. _d21 cm
225			_aEMCDDA - Risk Assessment _v6
300			_aInformação sobre EMCDDA pode ser encontrada no site: https://www.emcdda.eu.int
330			_aCoucil decision. Cha.1 - Reports on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetyic drugs. Cha.2 - Europol-EMCDDA progress report on 2C-I, 2C-T-2 and 2C-T-7. Cha.3 - Review of the pharmacotoxicological data on 2C-I, 2C-T-2 and 2C-T-7. Cha.4 - Sociological and criminological evidence and public health risks of 2C-I, 2C-T-2 and 2C-T-7. Participants in the risk assessment process. Text of the joint action.
606			_aSAÚDE PÚBLICA _91370
606			_aCONSUMO DE DROGA _95102
606			_aTOXICODEPENDÊNCIA _94612
606			_aTIPOS DE DROGA _96299
606			_aUNIÃO EUROPEIA _9100
606			_aRELATÓRIO ANUAL _9299235
710			_aEUROPEAN MONITORING CENTER FOR DRUGS AND DRUG ADDICTION - EMCDDA _98685
852			_jDRO211